REGISTERED
on 07 May 2024
Last Applicant/ Owned by
Seocho-gu Seoul
KR
Serial Number
79362319 filed on 12th Jan 2023
Registration Number
7376585 registered on 07th May 2024
Correspondent Address
Kwang Yup Chae
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
RECEPTKINE
Laboratory services relating to the production of monoclonal antibodies; Research and development of vaccines and medicines; Consultancy in the field of biotechnology; Research and development of technology for biotechnology; Scientific research in the field of biomedicine; Biological research; Biochemical research; Providing information relating to scientific research in the fields of biochemistr Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Laboratory services relating to the production of monoclonal antibodies; Research and development of vaccines and medicines; Consultancy in the field of biotechnology; Research and development of technology for biotechnology; Scientific research in the field of biomedicine; Biological research; Biochemical research; Providing information relating to scientific research in the fields of biochemistry and biotechnology; Drug discovery services; Development of pharmaceutical preparations and medicines; Testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; Scientific research in the field of pharmacy; Scientific research in the field of genetic engineering; Medicine research; Laboratory research services relating to pharmaceuticals; Medical and pharmacological research services; Medical research; Medical and pharmacological research, namely, clinical trials for others; Blood analysis services for scientific research purposes; Chemical engineering
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for immunity adjustment; Antibodies for veterinary purposes; Chemico-pharmaceutical preparations for use in the treatment of cancer, immune system related diseases and disorders; Albuminous preparations for medical purposes; Drugs for medical purposes, namely, for use in the treatment of cancer, immune system related diseases and disorders; Colostral antibodies for medical purposes; Antibody reagents for medical purposes for use in the treatment of cancer; Blood for medical purposes; Enzymes for medical purposes; Pharmaceutical drugs for use in the treatment of cancer, immune system related diseases and disorders; Human immune globulin; Medicines for human purposes, namely, for use in the treatment of cancer, immune system related diseases and disorders; Human plasma protein being blood plasma; Pharmaceutical preparations for use in the treatment of cancer, immune system related diseases and disorders; Haematogen, namely, blood substitutes for human use; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Antivirals; Antigens for use in the treatment of cancer; Antibody reagents used for the detection of the antigens in cells and tissue for medical purposes; Pharmaceutical preparations for use in hematology
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79362319
Mark Type
No Service Mark
Attorney Docket Number
No 6809-0016TM
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 04th Nov 2024 | FINAL DISPOSITION PROCESSED |
| 04th Nov 2024 | FINAL DISPOSITION NOTICE SENT TO IB |
| 07th Aug 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 07th May 2024 | REGISTERED-PRINCIPAL REGISTER |
| 07th May 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 04th Mar 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 27th Feb 2024 | NOTIFICATION PROCESSED BY IB |
| 20th Feb 2024 | PUBLISHED FOR OPPOSITION |
| 07th Feb 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 07th Feb 2024 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |